Literature DB >> 8713652

Prolactin and growth hormone in perinatal asphyxia.

A Varvarigou1, A G Vagenakis, M Makri, C Frimas, N G Beratis.   

Abstract

To assess the pituitary response to perinatal asphyxia, the prolactin (PRL) and growth hormone (hGH) serum concentrations were measured in 55 asphyctic (15 preterm and 40 full-term) and 35 control (15 preterm and 20 full-term) newborns at 2-4, 24, 48 and 98 h of life. At 2-4 h the median PRL in the preterm asphyctic neonates was 5.2 U/l, whereas in the preterm control newborns it was 3.2. In the full-term newborns with and without hypoxic-ischaemic encephalopathy (HIE) it was 5.8 and 3.4, respectively. In the full-term neonates with HIE the PRL remained significantly higher than in the controls up to the fourth day. At 2-4 h the median hGH in the preterm asphyctic and control newborns was 106.2 and 54.8 mU/l, respectively. In full-term newborns it was 85.0 and 40.8, respectively. The lowest hGH concentrations were found in the severe HIE. The increased PRL and hGH in asphyxia may result from a stress-related hormone release, whereas the very low hGH concentrations in severe HIE may result from a damage at the hypothalamic-hypophyseal axis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8713652     DOI: 10.1159/000244281

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  2 in total

1.  Plasma prolactin concentrations after caesarean section or vaginal delivery.

Authors:  L Heasman; J A Spencer; M E Symonds
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

2.  Time dependent impact of perinatal hypoxia on growth hormone, insulin-like growth factor 1 and insulin-like growth factor binding protein-3.

Authors:  Ömer Kartal; Seçil Aydınöz; Ayşe Tuğba Kartal; Taha Kelestemur; Ahmet Burak Caglayan; Mustafa Caglar Beker; Ferhan Karademir; Selami Süleymanoğlu; Mustafa Kul; Burak Yulug; Ertugrul Kilic
Journal:  Metab Brain Dis       Date:  2016-03-04       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.